R&D,AI & ML,News

Why the Decline in Pharma R&D?

3 years ago By Josh Neil

For a few decades now there has been a narrative in the pharmaceutical sector that R&D productivity has been steadily declining: thanks to a lack of low-hanging fruit, blockbuster drugs have been harder and harder to find. AI promises a possible solution for this decline: but is the reduction in productivity a real challenge in the industry? Is AI the only means of solving it? To what extent will AI really boost the finding of drugs in a crowded market?

To clarify the area for professionals who need to know, Proventa International created a White Paper on AI in R&D, looking at the innovations and trends shaping 2020, expert opinion on AI’s impact on R&D, and whether AI can reverse the steady decline in pharma R&D output. Below is just a sample of the full White Paper: to read the larger report, click here.

If you are unable to see the PDF below, please click here.

For more information on future events, including the upcoming Clinical OperationsCTSC and Pharmacovigilance meetings in November 2020, click here.

Joshua Neil, Editor
Proventa International

More news

RNA Therapeutics: The World’s First mRNA Malaria Vaccine

Malaria represents one of the greatest unmet clinical needs in the world. In the last decade, research has been ongoing to develop effective preventative methods and effective treatment to reduce the risk of severe illness, which typically occurs in children....

2 years ago
R&D,AI & ML,News

RNA Therapeutics: The World’s First mRNA Malaria Vaccine

Malaria represents one of the greatest unmet clinical needs in the world. In the last decade, research has been ongoing to develop effective preventative methods and effective treatment to reduce the risk of severe illness, which typically occurs in children....

2 years ago

Intrinsically Disordered Proteins – The Implication in Cancer and Potential Drug Targets

Intrinsically disordered proteins (IDPs) are under the limelight in cancer research. While research is continuous in understanding their dynamic structure, their implication in tumour development is becoming increasingly evident. Some of the latest advancements demonstrate how IDPs can be used...

2 years ago
R&D,AI & ML,News

Intrinsically Disordered Proteins – The Implication in Cancer and Potential Drug Targets

Intrinsically disordered proteins (IDPs) are under the limelight in cancer research. While research is continuous in understanding their dynamic structure, their implication in tumour development is becoming increasingly evident. Some of the latest advancements demonstrate how IDPs can be used...

2 years ago

DeepMind’s AI Predicts Structures for More Than 350,000 Proteins

In 2003, researchers sequenced approximately 92% of the human genome, a huge achievement and very recently researchers have completed the entire process. Now, the latest innovation in AI technology has predicted the structure of nearly the entire human proteome. The...

2 years ago
R&D,AI & ML,News

DeepMind’s AI Predicts Structures for More Than 350,000 Proteins

In 2003, researchers sequenced approximately 92% of the human genome, a huge achievement and very recently researchers have completed the entire process. Now, the latest innovation in AI technology has predicted the structure of nearly the entire human proteome. The...

2 years ago